Why he received the 2026 prize
The Keio Medical Science Prize recognized Seishi Ogawa for elucidating principles of cancer development and evolution through advanced genomic analysis. The official profile highlights work spanning hematologic malignancies, solid tumors, clonal hematopoiesis and somatic mutations accumulating in normal tissues.
Why patients may care
This body of research supports the modern view of cancer through molecular alterations and clonal evolution and underpins the broader field of cancer genomic medicine. It does not mean that a genomic panel will necessarily produce an actionable drug for an individual patient.
Useful search concepts
Seishi Ogawa, cancer genomics, clonal hematopoiesis, somatic mutation and myelodysplastic syndrome. LINK MT connects researcher-name searches to practical pages on genomic medicine, pathology review and trials.
Primary and official sources
Japan medical enquiry
LINK MT supports evidence review, record preparation and coordination. Diagnosis, treatment and acceptance are decided by medical providers.
080-9240-2947LINE / WeChat / Contact